Arginine vasopressin disposition in the conscious rabbit.
To characterize the urinary kinetics of AVP, and the influence of regional blood flow on the metabolic degradation of AVP, multiple doses of AVP were administered to conscious rabbits. AVP systemic clearance (ClT) was not influenced by changes in dose, in spite of a decrease in AVP urinary clearance following the highest dose. Hepatic blood flow was inversely associated with AVP concentrations, and despite a decrease in hepatic plasma flow of 37% (p < 0.05), following the high dose of AVP, ClT remained unchanged. These results indicate that AVP plasma kinetics are first order and plasma flow independent, and urinary kinetics are zero order.
Lécrivain
A
A
Department of Pharmacology, University of Montréal, Québec, Canada.
Pichette
V
V
Ong
H
H
Homsy
W
W
Du Souich
P
P
D000818:Animals; D001127:Arginine Vasopressin / Q000008:administration & dosage / Q000097:blood* / Q000652:urine*; D001711:Biotransformation; D007275:Injections, Intravenous; D007700:Kinetics; D008102:Liver Circulation; D008297:Male; D011817:Rabbits; D012039:Regional Blood Flow; D012079:Renal Circulation
D001127:Arginine Vasopressin